Summary - AADI - NASDAQ - Weiss Ratings

E

Aadi Bioscience, Inc. AADI

$1.68 -$0.10-5.62%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$1.55 - $8.60

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Report

Biotechnology Health Care Pharmaceutical

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

Head-To-Head Comparison: Aadi Bioscience (NASDAQ:AADI) versus Statera Biopharma (NASDAQ:STAB)

4/21/2024 - Zolmax

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Update

4/15/2024 - Ticker Report

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Declines By 16.5%

4/14/2024 - Zolmax

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting

4/9/2024 - PR Newswire

Is Aadi Bioscience (AADI) Stock Outpacing Its Medical Peers This Year?

4/3/2024 - Zacks Investment Research

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Update

4/1/2024 - Zolmax

Aadi Bioscience, Inc. Forecasted to Post Q1 2024 Earnings of ($0.62) Per Share (NASDAQ:AADI)

3/21/2024 - Zolmax

Is Aadi Bioscience (AADI) Outperforming Other Medical Stocks This Year?

3/18/2024 - Zacks Investment Research

Aadi Bioscience (AADI) Receives a Hold from H.C. Wainwright

3/18/2024 - TipRanks Financial Blog

Aadi Bioscience presents new subgroup analysis in advanced malignant PEComa

3/17/2024 - The Fly

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)

3/17/2024 - PR Newswire

Aadi Bioscience, Inc. (NASDAQ:AADI) Q4 2023 Earnings Call Transcript

3/15/2024 - Insider Monkey

Aadi Bioscience Full Year 2023 Earnings: US$2.44 loss per share (vs US$2.69 loss in FY 2022)

3/14/2024 - Simply Wall St

Head to Head Comparison: Aadi Bioscience (NASDAQ:AADI) & Takeda Pharmaceutical (NYSE:TAK)

3/14/2024 - Ticker Report

Q4 2023 Aadi Bioscience Inc Earnings Call Transcript

3/14/2024 - GuruFocus

TD Cowen Keeps Their Buy Rating on Aadi Bioscience (AADI)

3/13/2024 - TipRanks Financial Blog

Aadi Bioscience, Inc. (AADI) Q4 2023 Earnings Call Transcript

3/13/2024 - Seeking Alpha: Transcripts

Aadi Bioscience, Inc. (AADI) Q4 2023 Earnings Call Transcript

3/13/2024 - SeekingAlpha

Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue Estimates

3/13/2024 - Zacks Investment Research

Aadi Bioscience reports Q4 EPS (60c), consensus (65c)

3/13/2024 - The Fly

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update

3/13/2024 - PR Newswire

Panorama des b n fices de Aadi Bioscience

3/12/2024 - Benzinga

NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates

3/11/2024 - Zacks Investment Research

Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates

3/7/2024 - Zacks Investment Research

Improved Revenues Required Before Aadi Bioscience, Inc. (NASDAQ:AADI) Stock's 28% Jump Looks Justified

3/7/2024 - Simply Wall St

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Wednesday, March 13, 2024

Period Date

Sunday, December 31, 2023

Next Filing

Week of May 6 and 10 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

--

5-Year Total Return

--

52-week Low

Jan 17, 2024 - $1.55

52-week High

May 23, 2023 - $8.60

Valuation

Market Cap

$45.18M - Nano Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

424-744-8055

Address

17383 Sunset Boulevard
Pacific Palisades, CA 90272

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead... more